These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist]. Yakuo I, Ishii K, Seto Y, Imano K, Takeyama K, Nakamura H, Karasawa T. Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558 [Abstract] [Full Text] [Related]
6. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects. Kreutner W, Hey JA, Anthes J, Barnett A, Young S, Tozzi S. Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633 [Abstract] [Full Text] [Related]
7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions. Gutiérrez B, Dordal A, Fort M, Galicia J, Farré AJ. Methods Find Exp Clin Pharmacol; 1996 Apr; 18(6):397-406. PubMed ID: 8892269 [Abstract] [Full Text] [Related]
8. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S, Ido T, Itoh M, Sasaki H, Watanabe T, Yanai K. Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858 [Abstract] [Full Text] [Related]
9. Preclinical comparison of ebastine and other second generation H1-antihistamines. Yakuo I, Yabuuchi M, Ito T. Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966 [Abstract] [Full Text] [Related]
10. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA, del Prado M, Sherwood J, Kreutner W, Egan RW. Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [Abstract] [Full Text] [Related]
11. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists. Böhme TM, Keim C, Kreutzmann K, Linder M, Dingermann T, Dannhardt G, Mutschler E, Lambrecht G. J Med Chem; 2003 Feb 27; 46(5):856-67. PubMed ID: 12593665 [Abstract] [Full Text] [Related]
14. Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. Weis R, Schweiger K, Faist J, Rajkovic E, Kungl AJ, Fabian WM, Schunack W, Seebacher W. Bioorg Med Chem; 2008 Dec 15; 16(24):10326-31. PubMed ID: 18977145 [Abstract] [Full Text] [Related]
15. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators. Fukuda T, Morimoto Y, Iemura R, Kawashima T, Tsukamoto G, Ito K. Arzneimittelforschung; 1984 Dec 15; 34(7):801-5. PubMed ID: 6149754 [Abstract] [Full Text] [Related]
17. Antagonism by imidazoline-type drugs of muscarinic and other receptors in the guinea-pig ileum. Salazar-Bookaman MM, Miller DD, Patil PN. Auton Autacoid Pharmacol; 2006 Jul 15; 26(3):267-73. PubMed ID: 16879492 [Abstract] [Full Text] [Related]
18. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality. Łazewska D, Kieć-Kononowicz K, Pertz HH, Elz S, Stark H, Schunack W. Pharmazie; 2002 Dec 15; 57(12):791-5. PubMed ID: 12561236 [Abstract] [Full Text] [Related]
19. A steric approach for the design of antihistamines with low muscarinic receptor antagonism. Zhang MQ, Walczynski K, Timmerman H. Inflamm Res; 1995 Apr 15; 44 Suppl 1():S90-1. PubMed ID: 8521019 [No Abstract] [Full Text] [Related]
20. Antimuscarinic actions of antihistamines on the heart. Liu H, Zheng Q, Farley JM. J Biomed Sci; 2006 May 15; 13(3):395-401. PubMed ID: 16453179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]